Flat type of intraductal papillary mucinous neoplasm of the pancreas differs from papillary or tubular types in terms of the expression of oncogenic protein and survival outcome

Pancreatology ◽  
2016 ◽  
Vol 16 (4) ◽  
pp. S73
Author(s):  
Jihoon Chang ◽  
Jin-Young Jang ◽  
Kyoungbun Lee ◽  
Mee Joo Kang ◽  
Woohyun Jung ◽  
...  
Keyword(s):  
Intraductal Papillary Mucinous Neoplasm ◽  
Survival Outcome ◽  
Mucinous Neoplasm ◽  
Flat Type ◽  
Oncogenic Protein

scholarly journals Small-Sized, Flat-Type Invasive Branch Duct Intraductal Papillary Mucinous Neoplasm: A Case Report

2013 ◽  
Vol 7 (3) ◽  
pp. 449-454 ◽  
Author(s):  
Koji Shindo ◽  
Junji Ueda ◽  
Shinichi Aishima ◽  
Akira Aso ◽  
Takao Ohtsuka ◽  
...  
Keyword(s):  
Case Report ◽  
Intraductal Papillary Mucinous Neoplasm ◽  
Branch Duct ◽  
Mucinous Neoplasm ◽  
Flat Type

scholarly journals Should Contrast-Enhanced Harmonic Endoscopic Ultrasound Be Incorporated into the International Consensus Guidelines to Determine the Appropriate Treatment of Intraductal Papillary Mucinous Neoplasm?

2021 ◽  
Vol 10 (9) ◽  
pp. 1818
Author(s):  
Tomohiro Yamazaki ◽  
Mamoru Takenaka ◽  
Shunsuke Omoto ◽  
Tomoe Yoshikawa ◽  
Rei Ishikawa ◽  
...  
Keyword(s):  
Intraductal Papillary Mucinous Neoplasm ◽  
Predictive Value ◽  
Diagnostic Value ◽  
Consensus Guidelines ◽  
International Consensus ◽  
Mucinous Neoplasm ◽  
Appropriate Treatment ◽  
Contrast Enhanced ◽  
Diagnostic Values ◽  
International Consensus Guidelines

This study aimed to investigate whether the incorporation of contrast-enhanced harmonic endoscopic ultrasound (CH-EUS) into the international consensus guidelines (ICG) for the management of intraductal papillary mucinous neoplasm (IPMN) could improve its malignancy diagnostic value. In this single-center retrospective study, 109 patients diagnosed with IPMN who underwent preoperative CH-EUS between March 2010 and December 2018 were enrolled. We analyzed each malignancy diagnostic value (sensitivity (Se), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV)) by replacing fundamental B-mode EUS with CH-EUS as the recommended test for patients with worrisome features (WF) (the CH-EUS incorporation ICG) and comparing the results to those obtained using the 2017 ICG. The malignancy diagnostic values as per the 2017 ICG were 78.9%, 42.3%, 60.0%, and 64.7% for Se, Sp, PPV, and NPV, respectively. The CH-EUS incorporation ICG plan improved the malignancy diagnostic values (Se 78.9%/Sp, 53.8%/PPV, 65.2%/NPV 70.0%). CH-EUS may be useful in determining the appropriate treatment strategies for IPMN.

Sign in / Sign up

Export Citation Format

Share Document